Psy Therapeutics, Inc. — Form D/A
Psy Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2023-08-10. The offering totals $20.4M, of which $4.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-08-10
- Form: D/A
- Accession: 0001104659-23-089899
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.4M
- Amount sold: $4.0M
- Remaining: $16.4M
- Investors: 10
- Date of first sale: 2021-12-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-426963
Issuer
- Name: Psy Therapeutics, Inc.
- CIK: 0001788222
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 28 ATLANTIC AVE, SUITE 222, BOSTON, MA, 02110
- Phone: (617) 723-5429
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| David S Barlow | Director | Boston, MA |
| David S Barlow | Executive Officer | Boston, MA |
| Paul F Murphy | Director | Boston, MA |
| Alan S Cross | Director | Boston, MA |
| Alan S Cross | Executive Officer | Boston, MA |
| William F Wagner | Executive Officer | Boston, MA |
| Jerry F Rosenbaum | Director | Boston, MA |
| Daniel S Weiss Pick | Director | Boston, MA |
| Jeff S Troderman | Executive Officer | Boston, MA |
| Bryan S Roberts | Director | Boston, MA |
| Brant S Binder | Director | Boston, MA |
| Brant S Binder | Executive Officer | Boston, MA |
Other filings by this issuer (4)
More